Lupin Receives Tentative FDA Approvals for Generic Nuvigil Tablets and Generic Oracea Capsules

A lot of pharmacologic treatments are currently being developed to combat sleep apnoea and its complications and symptoms. Recently, Lupin, an Indian pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally has received approval for its Armodafinil Tablets, 50 mg, 100 mg, 150 mg, 200 mg and 250 mg strengths as well as another tentative approval for its Doxycycline Capsules, 40 mg (30 mg Immediate-release and 10 mg Delayed-release) from the United States Food and Drugs Administration (FDA). Nuvigil is a drug used to improve wakefulness in adult patients with excessive sleepiness associated with treated obstructive sleep apnoea (OSA), narcolepsy, or shift work disorder.

Read more here:

http://www.dnaindia.com/pressreleases/1868290/press-release-lupin-receives-tentative-fda-approvals-for-generic-nuvigil-tablets-and-generic-oracea-capsules

Somnowell Inventor - Visiting Professor Simon Ash FDS MSc MOrth BDS

Prof. Ash is the inventor of the highly successful SOMNOWELL Chrome device for snoring and sleep apnoea.

The Somnowell Chrome is made to exacting standards in the Somnowell laboratory under the supervision of Visiting Professor Simon Ash. Prof. Ash and his master technicians create each Somnowell Chrome device using their wealth of experience and expertise.

Prof. Ash works at the forefront of his profession. He is a Consultant and Specialist Orthodontist with over 30 years clinical experience, with a special interest in sleep related breathing disorders, TMJD, and bruxism. He currently works in Harley Street London and two private hospitals in London as part of a multi-disciplinary team managing snoring and sleep apnoea, and is Visiting Professor of Orthodontics at the BPP University.